Synchronous Multiple Non-small Cell Lung Cancers:Molecular Staging and Survival Outcomes
Identification of clonal origins of synchronous, multiple lung cancers (SMLC) are important for both therapeutic and prognostic purposes.This study was aimed to develop a reliable approach to address this issue.Resected specimens of SMLC were assessed by the current guidelines, histology, and driver-gene mutation testing.
Yiliang Zhang Haichuan Hu Rui Wang Ting Ye Longlong Shao Yunjian Pan Lei Wang Yuan Li Lei Shen Yongfu Yu David Garfield Yihua Sun Haiquan Chen
Department of Thoracic Surgery, Fudan University Shanghai Cancer Center;Department of Oncology, Shan Department of Pathology, Fudan University Shanghai Cancer Center;Department of Oncology, Shanghai Me Department of Biostatistics, School of Public Health, Fudan University, Shanghai, China ProMed Cancer Centers, Shanghai, China
国内会议
厦门
英文
9-10
2013-09-25(万方平台首次上网日期,不代表论文的发表时间)